Overview
TERACRYSTAL provides solid-state, crystallization and analytical services for small organic molecules and peptides, across the entire drug development process. With the right combination of expertise, state-of-the-art equipment and resources, TeraCrystal is ready and well-placed to solve the most complex solid state and crystallization issues, to develop best-in-class solutions for our clients and to reduce the risk of failure at later stages.
In many types of our solid-state studies, we integrate in silico calculations that provide useful and fast information that significantly reduces the experimental work needed. The combination of predictive/modelling tools with solid-state and process development work not only gives us the opportunity to optimise our screening work and accelerate the delivery time, but also optimises the drug candidate selection.
